Voorbeelden van het gebruik van Relistor in het Engels en hun vertalingen in het Nederlands
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Computer
-
Ecclesiastic
-
Official/political
-
Programming
How is Relistor used?
Relistor pre-filled syringe.
Other information about Relistor.
How has Relistor been studied?
If you stop using Relistor.
Why has Relistor been approved?
Important information about some of the ingredients of Relistor.
Relistor methylnaltrexone bromide.
The full EPAR for Relistor can be found here.
Relistor is a solution for injection.
What benefit has Relistor shown during the studies?
Relistor is given as a subcutaneous injection.
Step 3: Injecting Relistor pre-filled syringe.
Relistor 12 mg Injection Methylnaltrexone bromide SC.
Instructions for preparing and giving an injection of relistor.
Relistor can be injected without regard to food.
The following instructions explain how to inject Relistor.
What Relistor looks like and contents of the pack?
Your doctor will decide if you can use Relistor if you are pregnant.
Relistor 8 mg injection Methylnaltrexone bromide SC.
These patients should use Relistor vials and not the pre-filled syringe.
Relistor 12 mg solution for injection in pre-filled syringe.
Cases of a hole developing in the bowel wall(gastrointestinal perforation) have been reported in patients using Relistor.
Do not use a Relistor pre-filled syringe more than one time,
syringe is empty and you hear a click to inject Relistor.
Relistor 8 mg solution for injection in pre-filled syringe Relistor 12 mg solution for injection in pre-filled syringe Methylnaltrexone bromide.
If you weigh less than 38 kg or more than 114 kg you should use Relistor vials because the correct dose cannot be accurately delivered with these pre-filled syringes.
treatment with usual laxatives should be stopped when starting Relistor.
In the second study, 52% of the patients receiving Relistor opened their bowels at least twice within four hours of the first four doses(32 out of 62),
The Committee for Medicinal Products for Human Use(CHMP) decided that Relistor' s benefits are greater than its risks for the treatment of opioid-induced constipation in advanced illness patients who are receiving palliative care when response to usual laxative therapy has not been sufficient.